ADIPOQ and obesity disorder: Circulating FGF-21 upregulates adiponectin in subcutaneous adipose tissue and elevated levels of FGF-21 in obesity have been proposed to serve as a defence mechanism to protect against systemic insulin resistance9, which may fit with the initial increase in FGF-21 observed at day 3.